Stay updated on Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial
Sign up to get notified when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.

Latest updates to the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page footer now shows Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.0%

- Check27 days agoChange DetectedBrno-Bohunice (Czechia, 625 00) was added as a study location and Brno - Bohunice was removed. A 'Show glossary' option was added and minor metadata updates were made (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0).SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3, a version update with no substantive changes to the trial details.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations section was updated to add many new sites across the US and internationally and to remove several existing location entries.SummaryDifference2%

- Check91 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Midostaurin + Chemotherapy in FLT3-MN AML Clinical Trial page.